
About Vanthys Pharmaceutical Development Private Limited
Data last updated:
Vanthys Pharmaceutical Development Private Limited was a private limited company based in Noida, Uttar Pradesh, India, operated as a subsidiary of Jubilant Innovation Pte. Limited. The company has been dissolved (liquidated) as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 11 May 2009.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U73100UP2009PTC037333. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹22.5 Cr and a paid-up capital of ₹22.5 Cr. It was led by directors including Benny Thomas and Shyamsundar Bang.
Its last annual general meeting (AGM) was held on 20 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2018, the company reported a revenue of ₹29.46 Lakh. For the same year it recorded a net profit of ₹20.55 Lakh (net margin 69.8%) and EBITDA of ₹27.56 Lakh (EBITDA margin 93.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.
The company was associated with 4 brands: Jubilant Biosys, Jubilant Pharma, Jubilant Pharmova and Jubilant Life Sciences. The company has 1 deal on record (1 acquisition); the latest was in January 2012. Its 10 peer companies in the Pharma industry (Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Orcivita Sciences and Research Private Limited with revenue of ₹31.4 Lakh.
The last known website on record is jubilantpharmova.com.
Company details
Contact details
Vanthys Pharmaceutical Development Private Limited's registered office is in Noida, Uttar Pradesh. Its website is jubilantpharmova.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Vanthys Pharmaceutical Development Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Vanthys Pharmaceutical Development operates multiple associated brands including Jubilant Biosys, Jubilant Pharma, and Jubilant Pharmova. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers integrated drug discovery, research, and manufacturing for pharmaceuticals. | jubilantbiosys.com | |
| Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | jubilantpharma.com | |
| CDMO focused on manufacturing of solid, semi solid, liquid, and injectible drug formulations | jubilantpharmova.com | |
| Company offering a suite of R&D and manufacturing services for small molecules and generics | jubl.com |
Financials of Vanthys Pharmaceutical Development Private Limited
FY 2018 filings availableVanthys Pharmaceutical Development Private Limited reported revenue of ₹29.46 Lakh for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹29.46 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹27.56 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹20.55 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 93.6% | |||
| Net Profit Margin | 69.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Vanthys Pharmaceutical Development Private Limited, buy the company report.
Board of directors and KMP of Vanthys Pharmaceutical Development Private Limited
Vanthys Pharmaceutical Development Private Limited currently reports 3 directors and 1 key managerial person. 18 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Benny Thomas Also directs: Sami Nutraceuticals Private Limited | Director | 28 Mar 2018 | 8 Years 7 Months | As last reported |
| Saravanakumar Dhakshinamoorthy | Additional Director | 15 May 2019 | 7 Years 6 Months | As last reported |
| Shwetank Tiwari Also directs: Sumant Investments Pvt.Ltd. | Company Secretary | 16 Jan 2018 | 8 Years 10 Months | As last reported |
| Shyamsundar Bang | Director | 28 Mar 2018 | 8 Years 7 Months | As last reported |
Peer comparison
Vanthys Pharmaceutical Development Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Orcivita Sciences and Research Private Limited | ₹31.4 Lakh (FY 2024) | 83.0% | Kolkata, West Bengal, India | |||
| Clinfound Diagnostics Private Limited | ₹30.82 Lakh (FY 2025) | -73.0% | Thodupuzha, Kerala, India | |||
| Smo Clinical Research (India) Private Limited | ₹30.36 Lakh (FY 2025) | -72.0% | Bangalore, Karnataka, India | |||
| P.T Healthcare Private Limited | ₹30.24 Lakh (FY 2025) | Nadia, West Bengal, India | ||||
| Suncure Pharmaceutical Private Limited | ₹30.11 Lakh (FY 2023) | -49.0% | Bangalore, Karnataka, India | |||
| Vanthys Pharmaceutical Development Private Limitedthis company | ₹29.46 Lakh (FY 2018) | ₹20.55 Lakh | 69.8% | Noida, Uttar Pradesh, India | ||
| Omicsgen Lifesciences Private Limited | ₹29.32 Lakh (FY 2024) | -25.0% | Kanayannur, Kerala, India | |||
| Ethitrials Contract Research Private Limited | ₹29.27 Lakh (FY 2024) | 20.0% | Ahmedabad, Gujarat, India | |||
| Chemengg Research Private Limited | ₹29.07 Lakh (FY 2024) | -13.0% | Pune, Maharashtra, India | |||
| Nkure Therapeutics Private Limited | ₹28.47 Lakh (FY 2025) | 87.0% | Bangalore, Karnataka, India | |||
| Solvitall Research Labs Private Limited | ₹28.07 Lakh (FY 2024) | Chengalpattu, Tamil Nadu, India |
To see the full peer comparison of Vanthys Pharmaceutical Development Private Limited, buy the company report.
Auditor
Vanthys Pharmaceutical Development Private Limited is audited by B S R & Co. LLP for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & Co. LLP | FY 2018 | 101248W/W100022 |
Shareholding
The shareholding of Vanthys Pharmaceutical Development Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Vanthys Pharmaceutical Development Private Limited, buy the company report.
Deals & funding
Vanthys Pharmaceutical Development Private Limited has 1 deal on record (1 acquisition); the latest was in January 2012.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2012 | Acquisition | Undisclosed | Buyer: Jubilant Pharmova Limited Seller: Eli Lilly and Co. |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Vanthys Pharmaceutical Development Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vanthys Pharmaceutical Development Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vanthys Pharmaceutical Development has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Vanthys Pharmaceutical Development Private Limited, buy the company report.
Recent activity
Vanthys Pharmaceutical Development Private Limited has 20 board changes on record since 2011: 4 appointments and 16 cessations. The latest: Shyamsundar Bang ceased to be Director on 03 Feb 2021.
11 earlier events are in the company report.
News
Frequently asked questions
Vanthys Pharmaceutical Development has been "Dissolved (Liquidated)" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.
Vanthys Pharmaceutical Development was a private limited company based in Noida, Uttar Pradesh, India. The company worked in pharma contract r and d, within the pharma industry. It was incorporated on 11 May 2009 and is registered under CIN U73100UP2009PTC037333. The company is recorded as dissolved (liquidated) in MCA records and no longer exists as a legal entity.
Vanthys Pharmaceutical Development was incorporated on 11 May 2009. It is registered with the Registrar of Companies, Kanpur.
Vanthys Pharmaceutical Development had 4 directors and KMP:
- Benny Thomas - Director
- Saravanakumar Dhakshinamoorthy - Additional Director
- Shyamsundar Bang - Director
- Shwetank Tiwari - Company Secretary
The CIN (Corporate Identification Number) of Vanthys Pharmaceutical Development is U73100UP2009PTC037333. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Vanthys Pharmaceutical Development is at 1A Sector 16A Institutional Area, Noida, Uttar Pradesh, India – 201301.
Vanthys Pharmaceutical Development can be reached through the website jubilantpharmova.com. Its registered office is in Noida, Uttar Pradesh, India.
The latest financial statements of Vanthys Pharmaceutical Development on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 20 September 2018. Year-wise statements from 2015 are in the company report.
No. Vanthys Pharmaceutical Development has 1 GST registration on record and it is cancelled or inactive.
Vanthys Pharmaceutical Development operated in the pharma industry, in the pharma contract r and d segment.
Vanthys Pharmaceutical Development has 1 deal on record (1 acquisition); the latest was in January 2012.

